Treatment for early-stage breast cancer is one of the great debates—and now, there’s been incredible progress in understanding whether women diagnosed with stage zero breast cancer, known as ductal ...

A newly released study is challenging the way doctors commonly treat patients with ductal carcinoma in situ (DCIS), known as stage zero breast cancer. DCIS cancer cells are confined inside a milk duct ...

A "watch-and-wait" strategy might be the best option for some women with early-stage, low-risk breast cancer. Photo by Adobe Stock/HealthDay News A "watch-and-wait" strategy might be the best option ...

When the results of her routine mammogram came back with a diagnosis of stage 0 DCIS breast cancer in multiple areas of her right breast, Athaliah McPherson, a hairstylist and mom of one, said she ...

Waiting and seeing is not often the strategy employed when it comes to treating breast cancer, but a new clinical trial by the University of California, San Francisco, researchers are doing just that.

In this phase 3 trial, researchers aimed to study the efficacy of tumor bed boost and moderately hypofractionated whole breast irradiation in patients with non-low-risk DCIS.

A polygenic risk score (PRS) may help identify women who are at a greater risk of developing a future breast cancer after treatment for in situ breast disease, a retrospective study suggests. The ...

SAN ANTONIO -- Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended treatment, the randomized COMET ...

Please provide your email address to receive an email when new articles are posted on . Women with DCIS who did not identify as white had greater reductions in mental health 2 years after treatment ...

CLEVELAND — Barbara Sandon Norris thought she had every reason to celebrate in May. Seven years cancer-free with a clean mammogram, the 72-year-old Cleveland woman almost skipped her routine follow-up ...